3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
12
Neoplasms
11
Brain Neoplasms
10
Lung Neoplasms
9
Glioma
9
Glioblastoma
9
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Rectal Neoplasms
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Multiple Myeloma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Anus Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Cancer, Papillary
2
Small Cell Lung Carcinoma
2
Recurrence
2
Oligodendroglioma
2
Neurotoxicity Syndromes
2
Neuroendocrine Tumors
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Interventions
Vortioxetine
1
Transcranial Magnetic Stimulation
1
Magnetic Resonance Spectroscopy
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Depressive Disorder, Major
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT01718730
2019-10-22
Cortical Excitability and Inhibition in MDD
Mayo Clinic
Completed
23 enrolled